BIOMAT Database Logo BIOMAT Database Logo

MicroRNAs in prostate cancer: Functional role as biomarkers. 2017

Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
Department of Urology, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA; Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, 44106, USA.

MicroRNAs (miRNAs) are small endogenous non-coding molecules that alters gene expression through post-transcriptional regulation of messenger RNA. Compelling evidence suggest the role of miRNA in cancer biology having potential as diagnostic, prognostic and predictive biomarkers. This review summarizes the current knowledge on miRNA deregulated in prostate cancer and their role as oncogene, tumor suppressor and metastasis regulators. The emerging information elucidating the biological function of miRNA is promising and may lead to their potential usefulness as diagnostic/prognostic markers and development as effective therapeutic tools for management of prostate cancer.

UI MeSH Term Description Entries
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
Prognostic microRNAs as biomarkers for prostate cancer.
January 2024, Journal of cancer research and therapeutics,
Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
The Potential of MicroRNAs as Prostate Cancer Biomarkers.
August 2016, European urology,
Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
January 2020, Critical reviews in oncology/hematology,
Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
Circulating microRNAs as potential new biomarkers for prostate cancer.
May 2013, British journal of cancer,
Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer.
January 2019, Critical reviews in eukaryotic gene expression,
Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
MicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer.
January 2014, American journal of clinical and experimental urology,
Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
Exosomal microRNAs as potential biomarkers in castration-resistant prostate cancer.
January 2015, European urology,
Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
microRNAs as cancer biomarkers.
January 2016, Scandinavian journal of clinical and laboratory investigation. Supplementum,
Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
MicroRNAs as cancer biomarkers.
January 2013, MicroRNA (Shariqah, United Arab Emirates),
Rajnee Kanwal, and Alexis R Plaga, and Xiaoqi Liu, and Girish C Shukla, and Sanjay Gupta
Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate Cancer.
June 2021, Biomedicines,
Copied contents to your clipboard!